Noah Hahn, M.D.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder (NCT03317158) | Noah Hahn, M.D. | 2017-11-21 |
Track Noah Hahn, M.D. automatically
Every clearance here is in the API, with alerts when new ones post.